| Recurrent ESR1–CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers J Veeraraghavan, Y Tan, XX Cao, JA Kim, X Wang, GC Chamness, ... Nature communications 5 (1), 4577, 2014 | 158 | 2014 |
| Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers JA Kim, Y Tan, X Wang, X Cao, J Veeraraghavan, Y Liang, DP Edwards, ... Nature communications 7 (1), 12991, 2016 | 60 | 2016 |
| Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer L Yu, Y Liang, X Cao, X Wang, H Gao, SY Lin, R Schiff, XS Wang, K Li Oncogene 36 (20), 2910-2918, 2017 | 56 | 2017 |
| NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α-and AP-1-mediated VEGFa transcription L Qin, Y Xu, Y Xu, G Ma, L Liao, Y Wu, Y Li, X Wang, X Wang, J Jiang, ... Oncotarget 6 (27), 23890, 2015 | 37 | 2015 |
| Epigenetic activation of HORMAD1 in basal-like breast cancer: role in Rucaparib sensitivity X Wang, Y Tan, X Cao, JA Kim, T Chen, Y Hu, M Wexler, X Wang Oncotarget 9 (53), 30115, 2018 | 31 | 2018 |
| Skp2 deficiency inhibits chemical skin tumorigenesis independent of p27Kip1 accumulation C Sistrunk, SH Kim, X Wang, SH Lee, Y Kim, E Macias, ... The American journal of pathology 182 (5), 1854-1864, 2013 | 21 | 2013 |
| Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis X Wang, C Sistrunk, ML Rodriguez-Puebla The American journal of pathology 178 (1), 345-354, 2011 | 19 | 2011 |
| Therapeutic targeting of nemo-like kinase in primary and acquired endocrine-resistant breast cancer X Wang, J Veeraraghavan, CC Liu, X Cao, L Qin, JA Kim, Y Tan, SK Loo, ... Clinical Cancer Research 27 (9), 2648-2662, 2021 | 6 | 2021 |
| Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development X Wang, C Sistrunk, PL Miliani de Marval, Y Kim, ML Rodriguez-Puebla Cell Cycle 11 (2), 335-342, 2012 | 4 | 2012 |
| Cyclin D3 deficiency inhibits skin tumor development, but does not affect normal keratinocyte proliferation SH Lee, X Wang, SH Kim, Y Kim, ML Rodriguez‑Puebla Oncology letters 14 (3), 2723-2734, 2017 | 3 | 2017 |
| Abstract P1-07-07: Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of estrogen-receptor positive breast cancers J Veeraraghavan, Y Tan, XX Cao, JA Kim, X Wang, DP Edwards, ... Cancer Research 75 (9_Supplement), P1-07-07-P1-07-07, 2015 | 2 | 2015 |
| Genomic deregulation and therapeutic role of the cell-cycle kinase TLK2 in more aggressive breast cancers JA Kim, Y Tan, X Wang, X Cao, J Veeraraghavan, Y Liang, DP Edwards, ... Cancer Research 75 (15_Supplement), 3032-3032, 2015 | 1 | 2015 |
| Abstract P6-04-25: Genomic Deregulation and Therapeutic Role of Nemo-like Kinase in Luminal B Breast Cancer X Cao, L Qin, JA Kim, Y Tan, X Wang, R Schiff Cancer Research 72 (24_Supplement), P6-04-25-P6-04-25, 2012 | 1 | 2012 |
| Abstract PD09-08: The potential role of TLK2 as a therapeutic target in breast cancer. JA Kim, X Cao, Y Tan, R Schiff, X Wang Cancer Research 72 (24_Supplement), PD09-08-PD09-08, 2012 | 1 | 2012 |
| Abstract P3-06-03: Dual p38/NLK kinase inhibitor as potential novel therapeutic agent for tamoxifen-resistant luminal breast cancer X Wang, X Cao, J Veeraraghavan, L Qin, JA Kim, Y Tan, SG Hilsenbeck, ... Cancer Research 78 (4_Supplement), P3-06-03-P3-06-03, 2018 | | 2018 |
| Evaluation of the dual p38/NLK kinase inhibitor as potential new therapeutic agent for tamoxifen-resistant breast cancer X Wang, X Cao, J Veeraraghavan, L Qin, JA Kim, Y Tan, SG Hilsenbeck, ... Cancer Research 77 (13_Supplement), 1223-1223, 2017 | | 2017 |
| Lack of cyclin D3 enhances the CDK6-dependent skin tumor susceptibility to malignant progression SH Lee, X Wang, ML Rodriguez-Puebla Cancer Research 74 (19_Supplement), 1323-1323, 2014 | | 2014 |
| Abstract P3-04-04: Amplification and overexpression of TLK2 promote genomic instability in invasive breast cancer JA Kim, X Cao, Y Tan, X Wang, R Schiff, X Wang Cancer Research 73 (24_Supplement), P3-04-04-P3-04-04, 2013 | | 2013 |
| Reduced tumor formation by forced expression of cyclin-dependent kinase 6 in mouse epidermis X Wang, C Sistrunk, M Rodriguez-Puebla Cancer Research 70 (8_Supplement), 3891-3891, 2010 | | 2010 |
| Abstract# 3315: Cyclin-dependent kinase 6 overexpression in epidermis of transgenic mice results in increase cdk6/cyclin D3 complexes, keratinocyte proliferation and apoptosis. X Wang, C Sistrunk, M Rodriguez-Puebla Cancer Research 69 (9_Supplement), 3315-3315, 2009 | | 2009 |
